Otolaryngology Doctors in Meridian, ID Accepting Medicare

6 Otolaryngology doctors found. Showing 1 - 6

Dr. Eric Peter Wilkinson, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1209 N Summerbrook Ave Ste 100, Meridian, ID 83642 Phone: 208-938-5823    Fax: 208-938-5306

Dr. James Vincent Crawford, MD Otolaryngology - Otology & Neurotology Medicare: Accepting Medicare Assignments Practice Location: 1209 N Summerbrook Ave Ste 100, Meridian, ID 83642 Phone: 208-938-5823    Fax: 208-938-5306

Lance Wayne Coleman, MD Otolaryngology - Plastic Surgery within the Head & Neck Medicare: Not Enrolled in Medicare Practice Location: 520 S Eagle Rd, #1223, Meridian, ID 83642 Phone: 208-888-4368

Dr. Jacob Scott Majors, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 875 S Vanguard Way Ste 200, Meridian, ID 83642 Phone: 208-463-3000

Dr. Peter James Killian, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1157 N Summerbrook Ave Ste 120, Meridian, ID 83642 Phone: 208-593-4484    Fax: 208-593-4491

John Boyajian, MD Otolaryngology - Otolaryngic Allergy Medicare: Accepting Medicare Assignments Practice Location: 3085 E Magic View Dr # 140, Meridian, ID 83642 Phone: 208-433-9300    Fax: 208-433-9854

News Archive

Recent clinical study sheds light on potential approach to more personalized care for pancreatic cancer

Pancreatic cancer is one of the deadliest cancers. Even with aggressive treatment, the prognosis is poor, with various factors stacking the odds against successful treatment: early detection is uncommon, it tends to spread quickly and recurrence is likely. However, several newer approaches show promise in increasing the response rate to pancreatic cancer treatment.

Stem cells give insight into path of cytomegalovirus infection

Primitive human stem cells are resistant to human cytomegalovirus, say researchers who believe this finding could provide further insight into disease pathology.

Promising new therapy for Alzheimer's

NewYork-Presbyterian Hospital/Weill Cornell Medical Center announced today the nine-month interim results of an ongoing Phase II clinical trial of GAMMAGARD Intravenous Immunoglobulin (IGIV) for Alzheimer's disease at the Alzheimer's Association International Conference on Alzheimer's Disease (ICAD) in Chicago.

Active surveillance can offer prostate cancer patients more individualized patient care

Active surveillance may be a viable option for some men, but reclassification of disease risk over time is imperative to ensure outcomes, according to researchers in Toronto, who will present these criteria during the 104th Annual Scientific Meeting of the American Urological Association (AUA).

Volunteering linked to better employment and health outcomes

Researchers of Ghent University analysed data on volunteering, employment and health of more than 40,000 European citizens. Their results, just published in PLOS ONE, show that volunteering is associated with better employment and health outcomes.

Read more Medical News

› Verified 7 days ago